Phase IIIB randomized study of Lexiva (FPV) [fosamprenavir] boosted with a reduced dose of ritonavir (RTF)
Latest Information Update: 03 Sep 2024
At a glance
- Drugs Fosamprenavir (Primary) ; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- 03 Sep 2024 Status changed from not stated to completed.
- 26 Sep 2006 New trial record.